BBC 29.87 Virtus LifeSci Biotech Clinical Trials ETF
| Range: | 16.88-31.99 | Vol Avg: | 1961 | Last Div: | 0.08 | Changes: | 0.35 |
| Beta: | 0.97 | Cap: | 0.01B | Currency: | USD | Exchange: | AMEX |
| Sector: | Financial Services | IPO: | Wed Dec 17 2014 | Empoloyees: | |||
| CUSIP: | 26923G301 | CIK: | 0001559109 | ISIN: | US26923G3011 | Country: | US |
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow